By Staff Report / Monday, November 9th, 2015 / Latest news / Comments Off on Santa Barbara’s Beneflex buys Newbury Park-based Insurance Dimensions
Santa Barbara-based Beneflex Insurance Services recently acquired Newbury Park-based Insurance Dimensions. Beneflex helps small- and medium-sized companies in the tri-county region navigate Affordable Care Act compliance and other issues regarding employee benefits. It acquired Insurance Dimensions on Oct. 1 to increase its client base throughout Santa Barbara and Ventura counties and benefit from owner/operator Aline Read More →
AppFolio founder and chief strategist Klaus Schauser Santa Barbara-based cloud computing firm AppFolio said revenue jumped 56 percent to $20.3 million for the third quarter as losses grew to $4.8 million. The company, which specializes in providing business-to-business cloud services, said that it had increased both law firm and property management Read More →
The Central Coast labor market is growing at a rate faster than the state’s, led by an all-time high in nonfarm employment, according to analysis from the Central Coast Economic Forecast. About 400 people flocked to the Madonna Inn in San Luis Obispo on Nov. 6 for the annual forecast. Chris Thornberg and Jordan Levine of Read More →
Thousand Oaks-based biotech giant Amgen announced on Nov. 6 that the Food and Drug Administration will review a new treatment for patients with chronic kidney disease. The new drug, Etelcalcetide, works by suppressing the secretion of a parathyroid hormone. The drug is administered intravenously three times per week at the end of a dialysis session. Read More →
Regulators have put crab season on ice. The tri-county commercial fishing industry is feeling the sting of a toxin that’s been found in some of the area’s seafood. The California Department of Public Health advised consumers in a Nov. 3 announcement not to eat Dungeness and rock crabs caught between the Oregon border and the Read More →
Port Hueneme-based Stellar Biotechnologies started trading on the Nasdaq stock exchange Nov. 5. Stellar makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California. Shares opened at $8.74 on Nov. 5 and were trading on the Nasdaq at $9.40 as of 11:30 Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
